Belgium

Back to map

Showing 1-10 of 12 grants

Title Institution Researcher Program Duration Total Award Amount
JDRF- European Diabetes Forum (EUDF) Partnership European Diabetes Forum (EUDF) Chantal Mathieu Transportfolio 01-May-2020 to 31-December-2026 $399,333.70
INNODIA non-profit Launch INNODIA iVZW Chantal Mathieu Cures 01-January-2023 to 31-December-2027 $1,735,792.00
Stratification of Obese Phenotypes to Optimize Future Obesity Therapy (IMI2 SOPHIA) Katholieke Universiteit Leuven Bart Van der Schueren Improving Lives 01-May-2020 to 31-January-2026 $1,129,525.00
EDENT1FI – European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception Katholieke Universiteit Leuven Chantal Mathieu Cures 01-November-2023 to 31-October-2028 $1,003,531.00
“SyneRegIm”: exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetes Katholieke Universiteit Leuven Chantal Mathieu Cures 01-September-2022 to 31-August-2025 $600,000.00
LACMETA – Manipulating lactate metabolism to regulate T cell responses in type 1 diabetes Université Libre de Bruxelles Alessandra Cardozo Cures 01-October-2025 to 30-September-2028 $200,000.00
Mining the transcriptomic signatures of pancreatic beta-cells and the target tissues of other autoimmune and inflammatory endocrine or brain diseases to identify common mechanisms and novel therapies Université Libre de Bruxelles Decio Eizirik Cures 01-May-2023 to 30-April-2026 $698,821.00
The central role for NLRC5 in the dialog between β-cells and the immune system in type 1 diabetes Université Libre de Bruxelles Decio Eizirik Cures 01-June-2022 to 30-November-2025 $598,503.00
SMART-ISLETs: Stem Cell-Derived Smart Islets for Improved Transplantation Outcome. Université Libre de Bruxelles Esteban Gurzov Cures 01-July-2024 to 30-June-2026 $269,778.00
Unveiling new targets to protect β-cells in type 1 diabetes via in-depth comparison between α- and β-cell features Université Libre de Bruxelles Maria Eugenia Martin-Vazquez Garcia Cures 01-May-2025 to 30-April-2028 $241,710.00